Jack A. Roth
Impact in
- Biotechnology top 1%
- Cancer Research and Treatments
- Oncology top 5%
- Cancer-related Molecular Pathways
- CAR-T cell therapy research
Papers in
-
- Cancer Research and Treatments 7
- Oncology 11
- Cancer-related Molecular Pathways 7
- CAR-T cell therapy research 2
- Co-authors
- Tapas MukhopadhyayElizabeth A. GrimmT. FujiwaraLaurie B. Owen‐SchaubWei Wei ZhangAlan G. CassonB. LevinPatricia E. Koch
- Journals
- Human Gene Therapy (2 papers)The Annals of Thoracic Surgery (2 papers)Molecular Medicine (2 papers)PLoS ONE (2 papers)Electrophoresis (1 paper)
- Partner nations
- United StatesNetherlandsAustralia
In The Last Decade
Jack A. Roth
28 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 95
- Biotechnology 457
- Oncology 906
- Genetics 725
- Molecular Biology 1.1k
- Cancer Research 200
Countries citing papers authored by Jack A. Roth
This map shows the geographic impact of Jack A. Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack A. Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack A. Roth more than expected).
Fields of papers citing papers by Jack A. Roth
This network shows the impact of papers produced by Jack A. Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack A. Roth. The network helps show where Jack A. Roth may publish in the future.
Co-authors
The 25 scholars most cited alongside Jack A. Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2013 | 16 | |
| 5 | 2003 | 26 | |
| 6 | 2001 | 20 | |
| 7 | 2001 | 65 | |
| 8 | 2001 | 11 | |
| 9 | Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. | 1999 | 211 |
| 10 | 1998 | 101 | |
| 11 | 1998 | 4 | |
| 12 | 1996 | 16 | |
| 13 | 1996 | 15 | |
| 14 | 1994 | 36 | |
| 15 | 1994 | 8 | |
| 16 | Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. | 1994 | 392 |
| 17 | 1993 | 18 | |
| 18 | 1993 | 85 | |
| 19 | Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis. | 1993 | 95 |
| 20 | 1986 | 6 |
About Jack A. Roth
Jack A. Roth is a scholar working on Biotechnology, Oncology, Genetics, Molecular Biology and Pathology and Forensic Medicine, having authored 28 papers that have together received 1.9k indexed citations. Recurring topics across this work include Virus-based gene therapy research (10 papers), Cancer Research and Treatments (7 papers), Cancer-related Molecular Pathways (7 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), RNA Interference and Gene Delivery (3 papers), Ubiquitin and proteasome pathways (3 papers), Lung Cancer Treatments and Mutations (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Biotechnology (457 citations), Oncology (906 citations), Genetics (725 citations), Molecular Biology (1.1k citations) and Cancer Research (200 citations). Jack A. Roth has collaborated with scholars based in United States, Netherlands and Australia. Frequent co-authors include Tapas Mukhopadhyay, Elizabeth A. Grimm, T. Fujiwara, Laurie B. Owen‐Schaub, Wei Wei Zhang, Alan G. Casson, B. Levin, Patricia E. Koch, Jae Y. Ro and Karen R. Cleary. Their work appears in journals such as Human Gene Therapy, The Annals of Thoracic Surgery, Molecular Medicine, PLoS ONE and Electrophoresis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.